Lumentum stock (LITE) jumps in regular session ahead of earnings — what’s driving the move
3 February 2026
1 min read

Lumentum stock (LITE) jumps in regular session ahead of earnings — what’s driving the move

New York, February 3, 2026, 12:24 EST — Regular session

Lumentum shares rose 4.9% to $444.23 by midday Tuesday, after fluctuating between $432.20 and $463.40. About 4.0 million shares have changed hands so far. (Lumentum Investor Relations)

Attention is back on Lumentum, a stock now tied to sky-high expectations. Shares have surged roughly 390% in the last year, turning every quarterly earnings announcement into a key moment for investors. (Barron’s)

Lumentum’s stock surged 8.1% on Monday, closing at $423.42, up from $391.84 on Friday, based on historical price data. (Investing.com)

The gain occurred despite a weaker broader market. The SPDR S&P 500 ETF Trust dropped 0.9%, and the Invesco QQQ Trust Series 1 slid 1.7%. Meanwhile, optical-focused rivals Coherent Corp and Ciena Corp. saw their shares rise.

Next up is guidance. In its last quarterly update, Lumentum forecasted fiscal second-quarter revenue between $630 million and $670 million, with a non-GAAP operating margin of 20% to 22%, and non-GAAP earnings per share ranging from $1.30 to $1.50. (“Non-GAAP” here excludes stock-based compensation and other charges.) CEO Michael Hurlston highlighted that the company is “well positioned to support the rapid expansion of AI compute.” (Lumentum Investor Relations)

A separate SEC filing revealed that director and interim chief procurement officer Harris Isaac Hosojiro received 629 shares from vested restricted stock units, a type of equity compensation. After 225 shares were withheld to cover taxes, he ended up with 12,009 shares. (SEC)

Bulls face a clear risk: expectations have soared following the stock’s sharp climb. A slip below the company’s previous guidance or a more cautious outlook on demand and margins might spark profit-taking.

Investors are holding tight for Tuesday’s post-close earnings and the follow-up conference call, looking for the next major catalyst—and any shift, up or down, in guidance.

UnitedHealth stock slips again as Truist, JPMorgan trim targets and Medicare Advantage rates loom
Previous Story

UnitedHealth stock slips again as Truist, JPMorgan trim targets and Medicare Advantage rates loom

Applied Materials stock slips despite fresh Wall Street target hikes — what’s behind AMAT’s move
Next Story

Applied Materials stock slips despite fresh Wall Street target hikes — what’s behind AMAT’s move

Go toTop